![WB analysis of MCF-7 (1),T47D (2), HEK293 (3), JURKAT (4), NIH3T3 (5) and F9 (6) cell lysate using GTX80409 SETDB1 antibody [5H6D4]. WB analysis of MCF-7 (1),T47D (2), HEK293 (3), JURKAT (4), NIH3T3 (5) and F9 (6) cell lysate using GTX80409 SETDB1 antibody [5H6D4].](https://www.genetex.com/upload/website/prouct_img/normal/GTX80409/GTX80409_20170912_WB_w_23061322_503.webp)
WB analysis of MCF-7 (1),T47D (2), HEK293 (3), JURKAT (4), NIH3T3 (5) and F9 (6) cell lysate using GTX80409 SETDB1 antibody [5H6D4].
SETDB1 antibody [5H6D4]
GTX80409
Overview
- SupplierGeneTex
- Product NameSETDB1 antibody [5H6D4]
- Delivery Days Customer7
- Application Supplier NoteWB: 1/500 - 1/2000. ELISA: 1/10000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- Clone ID5H6D4
- FormulationLiquid
- Gene ID9869
- Target nameSETDB1
- Target descriptionSET domain bifurcated histone lysine methyltransferase 1
- Target synonymsERG-associated protein with a SET domain, ESET; ESET; H3-K9-HMTase4; histone H3-K9 methyltransferase 4; histone-lysine N-methyltransferase SETDB1; histone-lysine N-methyltransferase, H3lysine-9 specific 4; KG1T; KMT1E; lysine N-methyltransferase 1E; SET domain bifurcated 1; TDRD21; tudor domain containing 21
- Protein IDQ15047
- Protein NameHistone-lysine N-methyltransferase SETDB1
- Scientific DescriptionThis gene encodes a histone methyltransferase which regulates histone methylation, gene silencing, and transcriptional repression. This gene has been identified as a target for treatment in Huntington Disease, given that gene silencing and transcription dysfunction likely play a role in the disease pathogenesis. Alternatively spliced transcript variants of this gene have been described.[provided by RefSeq, Jun 2011]
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203